Skip to main content

Implanon: Subdermal Single Rod Contraceptive Implant

Abstract

Objectives

Study was conducted to determine acceptability, efficacy, safety, return of fertility with Implanon.

Methods

Volunteers having regular menstruation, requiring spacing formed study population. Implanon was inserted within 5 days of LMP or concurrent with MTP. Woman was asked to record bleeding pattern, side effects. Implanon duration was 3 years but Implanon was removed before, if patient wanted pregnancy/for side effects. Subjects who did not adopt family planning method after removal were followed up for return of ovulation and pregnancy.

Results

200 subjects were enrolled (160 within 5 days of LMP, 40 concurrent with MTP). 74 implanon removals were done. (16 after tenure completion, 58 for other reasons.) 16% cases discontinued implanon for polymenorrhagia, 10% for irregular bleeding, 4.5% for amenorrhea. There was no failure of implanon. 40% had return of ovulation within one month, 95.8% conceived within 12 months.

Conclusions

Implanon is safe, effective, well accepted method of contraception.

This is a preview of subscription content, access via your institution.

References

  1. Merki Feld GS, Imthurn B, Seifert B. Effects of the progestagen-only contraceptive Implant Implanon((R)) on cardiovascular risk factors. Clin Endocrinol (Oxf). 2008;68(3):355–60.

    CAS  Google Scholar 

  2. Wechselberger G, Wolfram D, Pulzl P, et al. Nerve injury caused by removal of an implantable hormonal contraceptive. Am J Obstet Gynecol. 2006;195:323–6.

    PubMed  Article  Google Scholar 

  3. Osman N, Dinh A, Durbert T, et al.. A new cause for iatrogenic lesion of the ulnar nerve at the arm: contraceptive hormonal implant. Report of two cases. Chir Main. 2005;24:181–3.

    PubMed  Article  CAS  Google Scholar 

  4. Harrrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception. 2005;71:306–8.

    Article  Google Scholar 

  5. Agrawal A, Robinson C. Spontaneous snapping of an Implanon in two halves in situ. J Fam Plann Reprod Health Care. 2003;29:238.

    PubMed  Article  Google Scholar 

  6. Lakha F, Glasier AF. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. Contraception. 2006;74:287–9.

    PubMed  Article  Google Scholar 

  7. Gezginc K, Belci O, Karatayli R, et al. Contraceptive efficacy, side effects of implanon(R). Eur J Contracep Reprod Health Care. 2007;12:362–5.

    Article  CAS  Google Scholar 

  8. Hidalgo MM, Lisondo C, Juliato CT, et al. Ovarian cysts in users of Implanon, Jadelle subdermal contraception implants. Contraception. 2006;73:532–6.

    PubMed  Article  CAS  Google Scholar 

  9. Hamontri S, Weerkul W. Implanon failure. J Med Assoc Thai. 2007;90:381–3.

    PubMed  Google Scholar 

  10. Mansour M, Louis-Sylvestre C, Paniel BJ. Ectopic pregnancy with etonogestrel contraceptive implant (Implanon): first case. J Gynecol Obstet Biol Reprod (Paris). 2005;34:608–9.

    CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Pushpa Bhatia.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bhatia, P., Nangia, S., Aggarwal, S. et al. Implanon: Subdermal Single Rod Contraceptive Implant. J Obstet Gynecol India 61, 422 (2011). https://doi.org/10.1007/s13224-011-0066-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13224-011-0066-z

Keywords

  • Implanon
  • Contraceptive
  • Etonogestrel